MSCFX
Price
$37.78
Change
+$0.43 (+1.15%)
Updated
Jul 31 closing price
Net Assets
259.68M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MSCFX vs NAESX

MSCFX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
MSCFX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCFX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. MSCFX (260M). NAESX pays higher dividends than MSCFX: NAESX (1.10) vs MSCFX (0.00). MSCFX was incepted earlier than NAESX: MSCFX (15 years) vs NAESX (66 years). MSCFX (0.97) is less costly to investors than NAESX (0.17). MSCFX is a more actively managed with annual turnover of: 19.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than MSCFX: NAESX (0) vs MSCFX (2500). MSCFX annual gain was more profitable for investors over the last year : 27.76 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. MSCFX (13.95).
MSCFXNAESXMSCFX / NAESX
Total Expense Ratio0.970.17571%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence15 years66 years-
Gain YTD21.24514.563146%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets260M189B0%
Annual Yield % from dividends0.001.100%
Returns for 1 year27.7622.56123%
Returns for 3 years28.8943.3067%
Returns for 5 years13.9534.9540%
Returns for 10 years75.86155.2849%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv